KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program ...

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program ...

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program ...

KNCV has been fighting TB in Nigeria for more than twenty years, with American support and hand in hand with the government. Nigeria is a high TB burden country where under diagnosis is a major challenge, meaning far too many patients do not receive proper treatment.

2024年12月27日 · Through a series of rigorous research publications, KNCV has contributed valuable insights that deepen our global understanding of TB trends and set the stage for innovative approaches in the years ahead.

2021年5月18日 · The BPaL regimen (consisting of the drugs pretomanid, bedaquiline and linezolid) was developed by TB Alliance and is implemented in Nigeria by the National TB Program (NTP), with support from KNCV Tuberculosis Foundation (KNCV).

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program ...

2023年12月11日 · The responsibility of the MATP will be to conduct a robust market analysis, design an appropriate access strategy and in coordination with KNCV Tuberculosis Foundation (KNCV) implement the proposed market shaping interventions of health products relevant to the drug-resistant tuberculosis cascade of care In Low- and Middle-Income Countries (LMICs).

2020年1月28日 · The SOS Stoolbox is KNCV’s online package to support countries with the implementation of the Simple One-Step (SOS) stool processing method for Xpert MTB/RIF or Xpert MTB/RIF Ultra assay testing for the detection of M. tuberculosis complex (MTBC) in stool. This simple stool processing method is limited to only one release-and-sedimentation step.

KNCV Tuberculosis Foundation is proud to be the lead partner of the Challenge TB project, the primary mechanism for implementing the United States Agency for International Development’s (USAID) vision of a world free of TB, and for supporting the global End TB Strategy.